HIV-1 gp120 third variable region (V3) crown
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain P; UniProt 306–328 | Not recorded | Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain × 1 Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;296 K;20% PEG 3350, 0.2 M NH4 citrate dibasic, VAPOR DIFFUSION, HANGING DROP, temperature 296K | Resolution 1.90 Å R-free 0.228 |
| 2 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain Q; UniProt 306–328 | Not recorded | Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain × 1 Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;296 K;20% PEG 3350, 0.2 M NH4 citrate dibasic, VAPOR DIFFUSION, HANGING DROP, temperature 296K | Resolution 1.90 Å R-free 0.228 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3MLX | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1ACY CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1 Deposited 1994-02-10 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
306–328(23 aa)
Fragment:FRAGMENT (RESIDUES 308 - 332)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 3.00 Å |
| 1AI1 HIV-1 V3 LOOP MIMIC Deposited 1996-11-06 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
306–328(23 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;pH 6.5
|
Resolution 2.80 Å |
| 1F58 IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323 Deposited 1998-10-21 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
306–328(23 aa)
Fragment:RESIDUES 308-332 FROM HIV-1 GP120
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.3;pH 6.3
|
Resolution 2.00 Å R-free 0.256 |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 240 PDB declaration: 240-MERIC |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 60 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Heteromer;Protein × 20 PDB declaration: eicosameric |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Insufficient information Heteromer;Protein × 24 PDB declaration: 24-meric |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1K5M Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2 Deposited 2001-10-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Insufficient information Heteromer;Protein × 60 PDB declaration: 60-meric |
Chain B
314–325(12 aa)
|
Not recorded | SPH SPHINGOSINE × 15 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M ammonium formate and 0.15 M sodium HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å |
| 1NIZ NMR structure of a V3 (MN isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody Deposited 2002-12-30 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
309–324(16 aa)
Fragment:V3 loop (residues 309-324)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR sample composition
U-15N; 10mM sodium acetate buffer pH=5 | 95% H2O/5% D2O
NMR sample composition
U-15N,13C; 10mM sodium acetate buffer pH=5 | 95% H2O/5% D2O
NMR sample composition
U-15N,13C; 10mM sodium acetate buffer pH=5 | 99% D2O
|
Resolution not provided |
| 1NJ0 NMR structure of a V3 (MN isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody Deposited 2002-12-30 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
309–324(16 aa)
Fragment:V3 loop (residues 309-324)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 10mM;Pressure ambient
NMR sample composition
U-15N; 10mM sodium acetate buffer pH=5 | 95% H2O/5% D2O
NMR sample composition
U-15N,13C; 10mM sodium acetate buffer pH=5 | 95% H2O/5% D2O
NMR sample composition
U-15N,13C; 10mM sodium acetate buffer pH=5 | 99% D2O
|
Resolution not provided |
| 2B0S Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide Deposited 2005-09-14 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
308–325(18 aa)
Fragment:residues 308-325
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 ACY ACETIC ACID × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;40% PEG 400, 0.2M potassium acetate, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 2.30 Å R-free 0.267 |
| 2QSC Crystal structure analysis of anti-HIV-1 V3-Fab F425-B4e8 in complex with a V3-peptide Deposited 2007-07-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
309–323(15 aa)
Fragment:Residues 301-326
|
Not recorded | ZN ZINC ION × 4 CL CHLORIDE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;298 K;PEG 8000, pH 6.0, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.80 Å R-free 0.264 |
| 3GO1 Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN Deposited 2009-03-18 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
309–322(14 aa)
|
Not recorded | SO4 SULFATE ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;296.15 K;30% PEG 8000, 0.2M Ammonium Acetate, 0.1M Sodium Cacodylate pH 6.5, vapor diffusion, hanging drop, temperature 296.15K
|
Resolution 1.89 Å R-free 0.213 |
| 3MLW Crystal structure of anti-HIV-1 V3 Fab 1006-15D in complex with an MN V3 peptide Deposited 2010-04-18 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
306–328(23 aa)
|
Not recorded | PO4 PHOSPHATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;20% PEG 3350, K dihydrogen phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 2.70 Å R-free 0.291 |
| 3MLW Crystal structure of anti-HIV-1 V3 Fab 1006-15D in complex with an MN V3 peptide Deposited 2010-04-18 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain Q
306–328(23 aa)
|
Not recorded | PO4 PHOSPHATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;20% PEG 3350, K dihydrogen phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 296K
|
Resolution 2.70 Å R-free 0.291 |
| 3UJI Crystal structure of anti-HIV-1 V3 Fab 2558 in complex with MN peptide Deposited 2011-11-07 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
306–328(23 aa)
Fragment:unp residues 306-328
|
Not recorded | CA CALCIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;296 K;85mM Hepes-Na, 15% Glycerol, 17% PEG 4k, 8.5% Isopropanol, pH 7.5, EVAPORATION, temperature 296K
|
Resolution 1.60 Å R-free 0.194 |
| 6SH9 EngBF DARPin Fusion 4b D12 Deposited 2019-08-06 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
310–323(14 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 MN MANGANESE (II) ION × 4 MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;277.15 K;PEG 20,000
MPD
MES
sodium chloride
manganese chloride
|
Resolution 2.40 Å R-free 0.193 |
| 9OP1 Cryo-EM structure of Candida albicans fluoride channel FEX in complex with Fab fragment Deposited 2025-05-16 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
670–686(17 aa)
Fragment:residues 76-389,residues 76-389
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.05 Å |
13 other PDB entries and 19 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | ENV_HV1MN |
| Isoform | — |
| PDB entities | 3 |
| Chains and sequence ranges | Author chain P; PDBConstruct 1–23; UniProt 306–328 Author chain Q; PDBConstruct 1–23; UniProt 306–328 |